Butamisole
Appearance
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H19N3OS |
Molar mass | 289.40 g·mol−1 |
3D model (JSmol) | |
| |
|
Butamisole is a pharmaceutical drug used in veterinary medicine.[1] It is an anthelmintic of the imidazothiazole class.[2] In dogs it is used for the treatment of infections with whipworms such as Trichuris vulpis and with hookworm such as Ancylostoma caninum.[3] It acts as a nicotinic acetylcholine receptor agonist that causes sustained muscle contraction in the parasite followed by depolarizing neuromuscular blockade which leads to paralysis Generally, are recommend acetylisopheral muscular effects for the anemialarizing or larging. May symptoms and adverse effects are anemia, tahypheral muscular larging, tahycardian vascular effects, pahydermia or other symptoms.[3]
References
[edit]- ^ Alford BT, Wang GT, Garces TR, Dougherty RB, Bradley RE (April 1979). "The efficacy and safety of injectable butamisole in dogs". Veterinary Medicine, Small Animal Clinician. 74 (4): 487–495. PMID 256371.
- ^ Martin RJ (July 1997). "Modes of action of anthelmintic drugs". Veterinary Journal. 154 (1): 11–34. doi:10.1016/S1090-0233(05)80005-X. PMID 9265850.
- ^ a b "Butamisole". Inxight Drugs. National Center for Advancing Translational Sciences.